SlideShare a Scribd company logo
1 of 68
Essential Medicines List: Concept and Procedures
1 |
WHO
ESSENTIAL MEDICINES LIST
WHO
ESSENTIAL MEDICINES LIST
Dr. AMREEN SABA ATTARIYA
POST GRADUATE STUDENT
DEPT OF PHARMACOLOGY
M.R. MEDICAL COLLEGE,
GULBARGA, INDIA
Essential Medicines List: Concept and Procedures
2 |
Outline of the presentation
 Background
 Evolution of WHO- Essential Medicine List(EML) (1977-2013)
 Approach for Revising/Updating the WHO Model EML
 Use of WHO Model EML and Implementation by National Health Systems
 Factors Affecting the Implementation of EML on Country Level
 Model EML
 India-National List of Essential Medicines(NLEM)
 Rational use of drugs
 Summary & References
Essential Medicines List: Concept and Procedures
3 |
 GUIDING PRINCIPLE: A limited range of carefully
selected essential drugs leads to Better health care, Better
drug management & at Lower costs
 DEFINITION: That satisfy the priority health care
needs of the population at all time.
 SELECTION: with due regard to public health relevance,
evidence of efficacy and safety, and comparative cost-effectiveness*
ESSENTIAL MEDICINES
*WHO, [Online]. http://www.who.int/topics/essential_medicines/en
Essential Medicines List: Concept and Procedures
4 |
EM are intended to be available
–at all times
– adequate amounts
–appropriate dosage forms
–assured quality & adequate information
–at a price the individual & community can
afford.
Essential Medicines List: Concept and Procedures
5 |
First country to compose its EML Tanzania in 1970
HISTORY OF WHO MODEL LIST OF ESSENTIAL
DRUGS
… 39 yrs of EML
• 1977 First Model list published, 204 active substances
List is revised every 2 years by WHO Expert Committee
April 2003 revised Model list --- 315 active substances
2007-EMLca separate list for children up to 12 years
Latest editions 19th adults & 5thchildren in April
2015(ammended Nov2015)*
*“WHO Model List of Essential Medicines: 18th list”, 2015.
Essential Medicines List: Concept and Procedures
6 |
CRITERIA FOR DRUG SELECTION FOR EML
Evidence of efficacy & safety
Relative cost effectiveness
Pharmacokinetics
Availability
Desired dosage form, bioavailability & stability ensured
Single compounds , in some cases FDCs
Essential Medicines List: Concept and Procedures
7 |
19th WHO Model List of Essential Medicines - 2015
Report of the WHO Expert Committee, 2015
Essential Medicines List: Concept and Procedures
8 |
Evolution of the WHO EML with Number of
Additions & Deletions
Essential Medicines List: Concept and Procedures
9 |
Significant changes from 1977 - 2013
Significant net changes in 1979 list
1988-Addition of FDC for TB
2007- newly developed vaccines for Hep-A,
rotavirus etc.
2013- Anti-retroviral drugs
Essential Medicines List: Concept and Procedures
10 |
CORE & COMPLEMENTARY LISTS
Core List Medicines
 minimum drug needs for a basic health care system
 most cost-effective drugs for priority conditions
Based on:
Efficacy & safety
Cost-effectiveness
Essential Medicines List: Concept and Procedures
11 |
Complementary List Medicines : Treat a priority condition
Require special:
Diagnostic or monitoring facilities
Medical care
Training
Consistently higher cost or minimal cost-effectiveness
Essential Medicines List: Concept and Procedures
12 |
SYMBOLS
square box symbol () - similar clinical performance
within a pharmacological class.
a- age or weight restriction on use of medicine
[c] -complementary list
[c] -specific indication for restricting its use in children
Essential Medicines List: Concept and Procedures
13 |
EML 2013 in numbers
Adult List
374 – total number of drugs/medicines
– Core list: 282 (FDC: 23)
– Complementary list: 68 (FDC: 1)
Pediatric List
278 in total
– Core list: 206 (FDC: 11)
– Complementary list: 60 (FDC: 1)
Essential Medicines List: Concept and Procedures
14 |
Trend for the Number of Medicines for Non-
Communicable Diseases
Essential Medicines List: Concept and Procedures
15 |
Trend for the Number of Medicines for Non-
Communicable Diseases…
Despite projections by the WHO that NCDs73% of
death burden & 60% of disease burden by 2020*
The ratio of medicines for NCD medicines to total
number of medicines in the WHO EML is constant at
~15% from 1977-2013
* WHO NCD surveillance strategy
Essential Medicines List: Concept and Procedures
16 |
Trend for Inclusion of Vaccine
WHO-Expanded Program on Immunization -1974 to cover 6 diseases*
*MA Miller, JT Sentz., Chapter 12,“Vaccine-Preventable Diseases”, in: DT Jamison, RG Feachem,
MW Makgoba, et al., editors. “Disease and Mortality in Sub-Saharan Africa”, 2nd
edition. Washington (DC): World Bank; 2006.
DIPHTHERIA PERTUSIS
TETANUS
TB POLIOMYELITIS MEASLES
Essential Medicines List: Concept and Procedures
17 |
Evolution of Vaccines in the WHO EML with
Number of Additions and Deletions
Cholera
HIB
Hepatitis A
JE
Pneumococcal
Rotavirus
varicella
Essential Medicines List: Concept and Procedures
18 |
Expansion of therapy classes(1977-2013)*
*“Selection of Essential Medicines – a Background Paper for theWorld
Medicines Situation 2010 Report”, 2009
Essential Medicines List: Concept and Procedures
19 |
Seven steps to get a new medicine on
the WHO Model List of Essential Drugs
1. Identification of public-health need for a medicine
2. Development of the medicine; phase I - II - III trials
3. Regulatory approval in a number of countries
4. Post-marketing surveillance
5. Price indication for public sector use
6. Review by WHO disease programme; define safety ,
comparative cost-effectiveness and public health relevance
7. Submission to WHO Expert Committee on Essential Drugs
Essential Medicines List: Concept and Procedures
20 |
PROCESS
EVIDENCE BASED & TRANSPARENT
Applications - addition/deletion /modification
Peer-reviewed by Expert Committee(EC)
Comments invited from any one interested
EC makes final decisions
Essential Medicines List: Concept and Procedures
21 |
The application form/template
Essential Medicines List: Concept and Procedures
22 |
Notable changes in EML since its inception
“Essential Drugs”  “Essential Medicines,”
Experience based Evidence based
Introduction of more rational selection process
Total treatment approach cost effectiveness approach
Essential Medicines List: Concept and Procedures
23 |
Important Events of EML*
*WHO, “Alliance for Health Policy and Systems Research;Medicines in
Health Systems: Advancing access, affordability and appropriate use”,
Flagship Report, 2014
Essential Medicines List: Concept and Procedures
24 |
Key Responsibilities of Different Stakeholders as
Defined at the Nairobi Conference-1985*
GOVERNMENT
Establish & implement national drug policy
Create awareness among health personnel & public
Increase registration of acceptable & safe drugs by setting
up or strengthening drug regulatory authority
*WHO, “The Rational Use of Drugs - Report of the Conference of
Experts, Nairobi 25-29 November 1985”,
Essential Medicines List: Concept and Procedures
25 |
PHARMACEUTICAL INDUSTRIES
Complete & unbiased product info to all -govt, prescribers &
consumers
Comply with established drug promotional criteria & adopt ethical
code for drug promotion
Respond to need of developing countries for low-cost drugs
Develop new drugs in neglected fields with high unmet needs
Essential Medicines List: Concept and Procedures
26 |
PRESCRIBERS
Prescribe rationally in conformity with health, social &
economic criteria
Transparent & accurate info on healthcare & drug therapy to
patients & public
Essential Medicines List: Concept and Procedures
27 |
UNIVERSITIES/ TEACHING INSTITUTIONS
Improve training of health workers in healthcare in general
& in rational use of drugs
Introduce the concept of essential drugs
Continuing education to health care providers
General education on proper health care & drug therapy
Essential Medicines List: Concept and Procedures
28 |
PUBLIC , PATIENT & CONSUMER
Improve relevance & quality of information for public
Share responsibility with govt. & non-govt.
organizations for education of consumers
Support essential drug program
Essential Medicines List: Concept and Procedures
29 |
MASS MEDIA
Provide relevant & balanced information on health
matters, including drug therapy
Share in public education on proper use of drug
therapy
Essential Medicines List: Concept and Procedures
30 |
Use of WHO Model List
Major International Agencies -UNICEF, UNHCR-
United Nations High Commissioner for Refugees
Sub-sets: UN list of recommended essential drugs for
emergency relief, interagency New Emergency
Health Kit.
Normative Tools: WHO Model Formulary,
International Pharmacopoea, Basic Quality Tests &
development of reference standards
Essential Medicines List: Concept and Procedures
31 |
Current Process and Steps in Updating
WHO Model EML
Essential Medicines List: Concept and Procedures
32 |
Use of WHO Model EML & Implementation
by National Health Systems
Guides the procurement & supply in public sector
Reimbursement schemes for medicine cost, medicine donation
& local production.
95% countries have NATIONAL LIST OF ESSENTIAL
MEDICINES(NLEM)of which 86% update once in 5yrs*
Few adopt EML at sub-national or state/provincial level
*WHO, “Backgrounder and Facts for Launch of the United Nations Report Delivering on the Global Partnerships for
Achieving The Millennium Development Goals”.
Essential Medicines List: Concept and Procedures
33 |
Number of countries with NLEM
National Essential Drugs List
< 5 years (127)
> 5 years (29)
No NEDL (19)
Unknown (16)
Essential Medicines List: Concept and Procedures
34 |
Difference between WHO-EML & NLEM
WHO EML- insulin & metformin “Medicines used for
Diabetics”
NLEM India & China- “Hormones, Other Endocrine Medicines
WHO EML-only names of medicines & recommended
formulations & strengths
NLEM-recommended standard treatment guidelines for the
specific indication in an attempt to align the EML with the
country-specific standard treatment guidelines.
Essential Medicines List: Concept and Procedures
35 |
Factors Affecting the Implementation of
EML on country level
Pricing Policy
Availability Of Essential Medicines
Reimbursement Scenario
Government Initiatives Supporting Implementation
Patent & Licensing Scenario
Healthcare Infrastructure
Essential Medicines List: Concept and Procedures
36 |
Essential Medicines List: Concept and Procedures
37 |
Access to Essential Medicines in Public and
Private Health Facilities
No. of people without access is high
A survey in 27 developing countries in
2007average availability of EM in public
sector- 34.9%, private sector- 63.2%*
*WHO, “Continuity and Change – Implementing the Third Who Medicines Strategy 2008 m-2013”, 2009.
Essential Medicines List: Concept and Procedures
38 |
Factors for Low availability of EML in public
sectors
underfunding or under-budgeting
inaccurate demand forecasting
inefficient public sector procurement & distribution of med
COMPELS PATIENTS INTO PRIVATE SECTOR
AVAILABILITY IS HIGH BUT COSTLY
Essential Medicines List: Concept and Procedures
39 |
Median Availability of Selected Generics in Public and Private
Health Facilities
Across Low and Middle Income Level Countries
Essential Medicines List: Concept and Procedures
40 |
Comparison of Medicines for Selected
NCDs and CDs
Essential Medicines List: Concept and Procedures
41 |
Content of EML
1 Anaesthetics
1.1 General anaesthetics and oxygen
1.2 Local anaesthetics
1.3 Preoperative medication and sedation for short-term procedures
2 Medicines for pain and palliative care
2.1 Non-opioids and non-steroidal anti-inflammatory drugs (NSAIDs)
2.2 Opioid analgesics
2.3 Medicines for other common symptoms in palliative care
3 Antiallergics and medicines used in anaphylaxis
4 Antidotes and other substances used in poisonings
4.1 Non-specific
4.2 Specific
5 Anticonvulsants/antiepileptics
6 Anti-infective medicines
6.1 Antihelminthics
6.2 Antibacterials
6.3 Antifungal medicines
6.4 Antiviral medicines
6.5 Antiprotozoal medicines
etc,……………………………………….
Essential Medicines List: Concept and Procedures
42 |
Content of EML
7 Antimigraine medicines
7.1 For treatment of acute attack
7.2 For prophylaxis
Hormones, other endocrine medicines and cont
Immunologicals
Ophthalmological preparations
Vitamins and minerals
Medicines for diseases of joints
Ear, nose and throat medicines in children
Cardiovascular medicines
Antiparkinsonism medicines
Diagnostic agents
Diuretics
Gastrointestinal medicines
Essential Medicines List: Concept and Procedures
43 |
Essential Medicines List: Concept and Procedures
44 |
Essential Medicines List: Concept and Procedures
45 |
INDIA - NLEM
Essential Medicines List: Concept and Procedures
46 |
Executive Core Committee INDIA
By Ministry of Health & Family Welfare (MOHFW), GOI
Under chairmanship of
Dr VM Katoch - Secretary, Department of Health Research (DHR)
and Director General ICMR
&
Dr YK Gupta- Vice Chairman, Professor and Head, Dept of
Pharmacology AIIMS.
Essential Medicines List: Concept and Procedures
47 |
Criteria For Inclusion Of Medicine In NLEM*
Be approved/licensed by DCGI.
Be useful in Disease which is a public health problem in India.
 Proven efficacy & safety profile based on valid scientific
evidence.
Be comparatively Cost effective.
Aligned with the current treatment guidelines for the disease.
Stable under the storage conditions in India.
*Report of core committee for revision of India NLEM Nov-2015
Essential Medicines List: Concept and Procedures
48 |
Criteria for Deletion of Medicine from NLEM
Medicines banned
Availability of med with better safety, efficacy & cost-
effectiveness.
Disease burden no longer health concern.
Antimicrobials resistance pattern rendered a
medicine ineffective.
Essential Medicines List: Concept and Procedures
49 |
Salient Features Of NLEM
First NLEM-1996
NLEM 2011  348 med
NLEM 2015  376 medicines(106 added & 70 deleted)
3 category included
 P→ Primary
 S → Secondary
 T → Tertiary
P,S,T ---206 drugs
S,T --- 115drugs
T --- 79 drugs.
Essential Medicines List: Concept and Procedures
50 |
NLEM 2015- BEST FIT LIST
Adhering To The Basic Principles Of
Efficacy
Safety
Cost-Effectiveness
Consideration of diseases as public health problems in India.
Essential Medicines List: Concept and Procedures
51 |
NLEM-2015
Essential Medicines List: Concept and Procedures
52 |
Essential Medicines List: Concept and Procedures
53 |
Essential Medicines List: Concept and Procedures
54 |
Essential Medicines List: Concept and Procedures
55 |
Essential Medicines List: Concept and Procedures
56 |
Practical Applications of EML
Policy making
Management
Selection
Procurement
Distribution
Quality assurance
Financing
Essential Medicines List: Concept and Procedures
57 |
Promoting rational use
Training of health Professionals
For providing medicines information & education
Cost effective therapy
Essential Medicines List: Concept and Procedures
58 |
Purpose of the NLEM
Guides safe and effective treatment of priority
disease conditions of a population
 Promote the rational use of medicines
Optimize the available health resources of a
country
Essential Medicines List: Concept and Procedures
59 |
NLEM-a guiding document for
State governments to prepare their list of essential medicines
Procurement and supply of medicines in the public sector
Reimbursement of cost of medicines by organizations to its
employees
Reimbursement by insurance companies
Identifying the ‘MUST KNOW’ domain for the teaching &
training of health care professionals
Essential Medicines List: Concept and Procedures
60 |
Rational use of dRugs
Essential Medicines List: Concept and Procedures
61 |
Rational use of Drug
Patients receive medications appropriate to their clinical needs, in doses that meet their own
individual requirements for an adequate period of time, and at the lowest cost to them
and their community.
WHO conference of experts Nairobi 1985
 correct drug
 appropriate indication
 appropriate drug considering efficacy, safety, suitability for the patient & cost
 appropriate dosage, administration, duration
 no contraindications
 correct dispensing, including appropriate information for patients
 patient adherence to treatment
Essential Medicines List: Concept and Procedures
62 |
Rational use of Drug*
RULE OF RIGHT
RIGHT DRUG to RIGHT PATIENT in RIGHT DOSAGE @ RIGHT
COST
SANE CRITERIA
SAFETY, AFFORDABILITY,NEED & EFFICACY
*HL Sharma & KL Sharma:Concept of EM & Rational drug use, p.no-106, 2nd
ed.
Essential Medicines List: Concept and Procedures
63 |
Factors Influencing Use of Medicines
Treatment
Choices
Prior
Knowledge
Habits
Scientific
Information
Relationships
With Peers
Influence
of Drug
Industry
Workload &
Staffing
Infra-
structure
Authority &
Supervision
Societal
Information
Intrinsic
Workplace
Workgroup
Social &
Cultural
Factors
Economic &
Legal Factors
Essential Medicines List: Concept and Procedures
64 |
SUMMARY
Defn: EM -that satisfy the priority health care needs of the population at
all time
Selection criteria: with due regard to public health relevance, evidence
of efficacy and safety & comparative cost-effectiveness
First model list-1977, revised every 2yrs, latest is 19th–
adults & 5th
-
children(2015)
Core list- basic min drugs for priority diseases
Complementary- which requires specialised health care facility
Essential Medicines List: Concept and Procedures
65 |
SUMMARY…
 Steps for getting new drug in model list
Identification of problem devp of med regulatory approval PMS
pricing review by WHO disease program submission to WHO EC.
 Changes since inception
EDL EML, experience evidence, total rxcost effectiveness
 Key responsibilties of govt, pharmac companies, prescribers, public, patient,
consumers & mass media
Essential Medicines List: Concept and Procedures
66 |
SUMMARY…
Factors affecting implementation
Pricing, availabilty, patent & licensing issues, health care infrastructure
Access to EML  public sector<<<<private sector
Uses of EML- Policy making, Management, Selection, Procurement,
Distribution, Financing, Promoting rational use, Training of health
Professionals, For providing medicines info & education, Cost effective
therapy
Essential Medicines List: Concept and Procedures
67 |
SUMMARY…
INDIA –NLEM
By MOHW- Govt Of India
3 categories- pri, sec & ter
NLEM-2015—376 molecules(BEST FIT LIST)
Adheres to safety, efficacy & cost-effective approach
Essential Medicines List: Concept and Procedures
68 |
References
 Understanding the Role and Use of EML: Murray Aitken Executive Director IMS
Institute for Healthcare Informatics, USA April 2015.
 WHO, [Online]. Available:
http://www.who.int/medicines/publications/essentialmedicines/en/
 WHO, “WHO Model List of Essential Medicines: 19th list”, 2015.
 Brian M. Kaiser : WHO’s EML: From Idea to Implementation
 WHO, “Essential Medicines for NCDs”, 2011.
 Report of core committee for revision of India NLEM Nov-2015
 HL Sharma & KL Sharma:Concept of EM & Rational drug use, p.no-106, 2nd
ed.

More Related Content

What's hot

Overview of Pharmacovigilance
Overview of PharmacovigilanceOverview of Pharmacovigilance
Overview of PharmacovigilanceAnindya Banerjee
 
Essential Medicines List
Essential Medicines ListEssential Medicines List
Essential Medicines ListLakshmi Ananth
 
Rational use of medicine
Rational use of medicineRational use of medicine
Rational use of medicineMuhammad Arsal
 
Sources of drug information
Sources of drug informationSources of drug information
Sources of drug informationSumit Kumar
 
Introduction to rational use of drugs and role of pharmacist in rational use...
Introduction to  rational use of drugs and role of pharmacist in rational use...Introduction to  rational use of drugs and role of pharmacist in rational use...
Introduction to rational use of drugs and role of pharmacist in rational use...Adhin Antony Xavier
 
Drug information and poison information
Drug information and poison informationDrug information and poison information
Drug information and poison informationTHUSHARA MOHAN
 
Patient medication adherence
Patient medication adherencePatient medication adherence
Patient medication adherenceRana Pelluri
 
DRUG-DOSE ADJUSTMENT IN PATIENTS WITH HEPATIC DISEASES
DRUG-DOSE ADJUSTMENT IN PATIENTS WITH HEPATIC DISEASESDRUG-DOSE ADJUSTMENT IN PATIENTS WITH HEPATIC DISEASES
DRUG-DOSE ADJUSTMENT IN PATIENTS WITH HEPATIC DISEASESDr.Amreen Saba Attariya
 
Essential medicine list
Essential medicine listEssential medicine list
Essential medicine listmigom doley
 
Rational use of antibiotics by RxVichuZ!
Rational use of antibiotics by RxVichuZ!Rational use of antibiotics by RxVichuZ!
Rational use of antibiotics by RxVichuZ!RxVichuZ
 

What's hot (20)

Overview of Pharmacovigilance
Overview of PharmacovigilanceOverview of Pharmacovigilance
Overview of Pharmacovigilance
 
OTC drugs
OTC drugsOTC drugs
OTC drugs
 
medication adherence
medication adherencemedication adherence
medication adherence
 
Essential Medicines List
Essential Medicines ListEssential Medicines List
Essential Medicines List
 
Rational use of medicine
Rational use of medicineRational use of medicine
Rational use of medicine
 
Counterfeit medicines
 Counterfeit medicines Counterfeit medicines
Counterfeit medicines
 
Sources of drug information
Sources of drug informationSources of drug information
Sources of drug information
 
Introduction to rational use of drugs and role of pharmacist in rational use...
Introduction to  rational use of drugs and role of pharmacist in rational use...Introduction to  rational use of drugs and role of pharmacist in rational use...
Introduction to rational use of drugs and role of pharmacist in rational use...
 
Pharmacovigilance
PharmacovigilancePharmacovigilance
Pharmacovigilance
 
Drug information and poison information
Drug information and poison informationDrug information and poison information
Drug information and poison information
 
Patient medication adherence
Patient medication adherencePatient medication adherence
Patient medication adherence
 
Good Pharmacy Practice
Good Pharmacy PracticeGood Pharmacy Practice
Good Pharmacy Practice
 
Rational drug use
Rational drug useRational drug use
Rational drug use
 
DRUG-DOSE ADJUSTMENT IN PATIENTS WITH HEPATIC DISEASES
DRUG-DOSE ADJUSTMENT IN PATIENTS WITH HEPATIC DISEASESDRUG-DOSE ADJUSTMENT IN PATIENTS WITH HEPATIC DISEASES
DRUG-DOSE ADJUSTMENT IN PATIENTS WITH HEPATIC DISEASES
 
Evidence based medicine
Evidence based medicineEvidence based medicine
Evidence based medicine
 
Pharmacovigilance
PharmacovigilancePharmacovigilance
Pharmacovigilance
 
Ward Round Participation
Ward Round ParticipationWard Round Participation
Ward Round Participation
 
Medication adherence
Medication adherenceMedication adherence
Medication adherence
 
Essential medicine list
Essential medicine listEssential medicine list
Essential medicine list
 
Rational use of antibiotics by RxVichuZ!
Rational use of antibiotics by RxVichuZ!Rational use of antibiotics by RxVichuZ!
Rational use of antibiotics by RxVichuZ!
 

Viewers also liked

Essential drug concept and rational use of medicines
Essential drug concept and rational use of medicinesEssential drug concept and rational use of medicines
Essential drug concept and rational use of medicinesPravin Prasad
 
Concept of essential medicines lhr 02 24-06
Concept of essential medicines lhr 02 24-06Concept of essential medicines lhr 02 24-06
Concept of essential medicines lhr 02 24-06Mian Quddus
 
"The Health System and Aid Effectives: Sudan's Experience"
"The Health System and Aid Effectives: Sudan's Experience""The Health System and Aid Effectives: Sudan's Experience"
"The Health System and Aid Effectives: Sudan's Experience"UWGlobalHealth
 
Myths about generic medicines
Myths about generic medicinesMyths about generic medicines
Myths about generic medicinesSastasundar
 
Comparative Effectiveness Research
Comparative Effectiveness ResearchComparative Effectiveness Research
Comparative Effectiveness ResearchRick Mathis
 
PYA Healthcare Thought Leader Explores Ten Technology “Game Changers”
PYA Healthcare Thought Leader Explores Ten Technology “Game Changers”PYA Healthcare Thought Leader Explores Ten Technology “Game Changers”
PYA Healthcare Thought Leader Explores Ten Technology “Game Changers”PYA, P.C.
 
National list of essential medicine final copy
National list of essential medicine  final copyNational list of essential medicine  final copy
National list of essential medicine final copynkar2429
 
A Comparative Study of Cost Effectiveness of Ibuprofen Suspensions with Other...
A Comparative Study of Cost Effectiveness of Ibuprofen Suspensions with Other...A Comparative Study of Cost Effectiveness of Ibuprofen Suspensions with Other...
A Comparative Study of Cost Effectiveness of Ibuprofen Suspensions with Other...iosrjce
 
Medicines outlook through 2016 report
Medicines outlook through 2016 reportMedicines outlook through 2016 report
Medicines outlook through 2016 reportAtef Khayat, MD, MBA
 
Rational Drug use - Group 5 presentation 2.0 bello edit
Rational Drug use - Group 5 presentation 2.0 bello editRational Drug use - Group 5 presentation 2.0 bello edit
Rational Drug use - Group 5 presentation 2.0 bello editCipriano Bello
 
Introducing new generic medicine on reimbursement list and influence over HIF...
Introducing new generic medicine on reimbursement list and influence over HIF...Introducing new generic medicine on reimbursement list and influence over HIF...
Introducing new generic medicine on reimbursement list and influence over HIF...Stevce Acevski
 

Viewers also liked (20)

Essential drug concept and rational use of medicines
Essential drug concept and rational use of medicinesEssential drug concept and rational use of medicines
Essential drug concept and rational use of medicines
 
Rational drug use
Rational  drug  useRational  drug  use
Rational drug use
 
Rational drug use
Rational drug useRational drug use
Rational drug use
 
Jsps showaprestn3
Jsps showaprestn3Jsps showaprestn3
Jsps showaprestn3
 
9a Alves Pharma
9a Alves Pharma9a Alves Pharma
9a Alves Pharma
 
Concept of essential medicines lhr 02 24-06
Concept of essential medicines lhr 02 24-06Concept of essential medicines lhr 02 24-06
Concept of essential medicines lhr 02 24-06
 
"The Health System and Aid Effectives: Sudan's Experience"
"The Health System and Aid Effectives: Sudan's Experience""The Health System and Aid Effectives: Sudan's Experience"
"The Health System and Aid Effectives: Sudan's Experience"
 
Rational drug use
Rational drug useRational drug use
Rational drug use
 
The Center for Comparative Effectiveness in Genomic Medicine 10.19.09
The Center for Comparative Effectiveness in Genomic Medicine 10.19.09The Center for Comparative Effectiveness in Genomic Medicine 10.19.09
The Center for Comparative Effectiveness in Genomic Medicine 10.19.09
 
Myths about generic medicines
Myths about generic medicinesMyths about generic medicines
Myths about generic medicines
 
Comparative Effectiveness Research
Comparative Effectiveness ResearchComparative Effectiveness Research
Comparative Effectiveness Research
 
PYA Healthcare Thought Leader Explores Ten Technology “Game Changers”
PYA Healthcare Thought Leader Explores Ten Technology “Game Changers”PYA Healthcare Thought Leader Explores Ten Technology “Game Changers”
PYA Healthcare Thought Leader Explores Ten Technology “Game Changers”
 
National list of essential medicine final copy
National list of essential medicine  final copyNational list of essential medicine  final copy
National list of essential medicine final copy
 
Generic Medicines
Generic MedicinesGeneric Medicines
Generic Medicines
 
Promoting Rational drugs in NRHM
Promoting Rational drugs in NRHMPromoting Rational drugs in NRHM
Promoting Rational drugs in NRHM
 
A Comparative Study of Cost Effectiveness of Ibuprofen Suspensions with Other...
A Comparative Study of Cost Effectiveness of Ibuprofen Suspensions with Other...A Comparative Study of Cost Effectiveness of Ibuprofen Suspensions with Other...
A Comparative Study of Cost Effectiveness of Ibuprofen Suspensions with Other...
 
Medicines outlook through 2016 report
Medicines outlook through 2016 reportMedicines outlook through 2016 report
Medicines outlook through 2016 report
 
Rational Drug use - Group 5 presentation 2.0 bello edit
Rational Drug use - Group 5 presentation 2.0 bello editRational Drug use - Group 5 presentation 2.0 bello edit
Rational Drug use - Group 5 presentation 2.0 bello edit
 
Introducing new generic medicine on reimbursement list and influence over HIF...
Introducing new generic medicine on reimbursement list and influence over HIF...Introducing new generic medicine on reimbursement list and influence over HIF...
Introducing new generic medicine on reimbursement list and influence over HIF...
 
What are Generic medicines ????
What are Generic medicines ????What are Generic medicines ????
What are Generic medicines ????
 

Similar to WHO Essential Medicine List, India's National List of Essential Med & Rational Use of Drugs

Essential drug concept & Rational drug use.pptx
Essential drug concept & Rational drug use.pptxEssential drug concept & Rational drug use.pptx
Essential drug concept & Rational drug use.pptxDr.Navaneethakrishnan S
 
Rational drug use and essential drugs
Rational drug use and essential drugsRational drug use and essential drugs
Rational drug use and essential drugsKoppala RVS Chaitanya
 
COMPILED VERSION Sbh who good pharmacy practice(gpp)
COMPILED VERSION Sbh who good pharmacy practice(gpp)COMPILED VERSION Sbh who good pharmacy practice(gpp)
COMPILED VERSION Sbh who good pharmacy practice(gpp)Sitaram Khadka
 
Essential medicines and counterfeit medicines
Essential medicines and counterfeit medicinesEssential medicines and counterfeit medicines
Essential medicines and counterfeit medicinesAmit Bhondve
 
Drug Utilization Studies
Drug Utilization StudiesDrug Utilization Studies
Drug Utilization StudiesZarrin Ansari
 
GROWTH OF PHARMACOVIGILANCE IN INDIA Dr Deven V Parmar MD Vice President – Gl...
GROWTH OF PHARMACOVIGILANCE IN INDIA Dr Deven V Parmar MD Vice President – Gl...GROWTH OF PHARMACOVIGILANCE IN INDIA Dr Deven V Parmar MD Vice President – Gl...
GROWTH OF PHARMACOVIGILANCE IN INDIA Dr Deven V Parmar MD Vice President – Gl...Until ROI
 
PV UTILISATION, APPLICATION WHO PROGRAMME.pptx
PV UTILISATION, APPLICATION WHO PROGRAMME.pptxPV UTILISATION, APPLICATION WHO PROGRAMME.pptx
PV UTILISATION, APPLICATION WHO PROGRAMME.pptxSAMYUKTHAKANDULA
 
Unit 3 drug utilization research (6hrs) march 12 2021
Unit 3 drug utilization research (6hrs) march 12 2021Unit 3 drug utilization research (6hrs) march 12 2021
Unit 3 drug utilization research (6hrs) march 12 2021University of Gondar
 
Drugs
DrugsDrugs
Drugsroh46
 
REGULATION OF COMPLEMENTARY MEDICINES.pptx
REGULATION OF COMPLEMENTARY MEDICINES.pptxREGULATION OF COMPLEMENTARY MEDICINES.pptx
REGULATION OF COMPLEMENTARY MEDICINES.pptxAmeena Kadar
 
Introduction_Pharmacotherapeutics.pptx
Introduction_Pharmacotherapeutics.pptxIntroduction_Pharmacotherapeutics.pptx
Introduction_Pharmacotherapeutics.pptxDr. Kiran Dhamak
 

Similar to WHO Essential Medicine List, India's National List of Essential Med & Rational Use of Drugs (20)

Hash 1-1.pptx
Hash 1-1.pptxHash 1-1.pptx
Hash 1-1.pptx
 
ESSENTIAL DRUGS.pptx
ESSENTIAL DRUGS.pptxESSENTIAL DRUGS.pptx
ESSENTIAL DRUGS.pptx
 
Essential drug concept & Rational drug use.pptx
Essential drug concept & Rational drug use.pptxEssential drug concept & Rational drug use.pptx
Essential drug concept & Rational drug use.pptx
 
Rational drug use and essential drugs
Rational drug use and essential drugsRational drug use and essential drugs
Rational drug use and essential drugs
 
Edl ppt
Edl pptEdl ppt
Edl ppt
 
WHO_Essential_Medicines_List_from_Idea_to_Implementation_FINAL.pdf
WHO_Essential_Medicines_List_from_Idea_to_Implementation_FINAL.pdfWHO_Essential_Medicines_List_from_Idea_to_Implementation_FINAL.pdf
WHO_Essential_Medicines_List_from_Idea_to_Implementation_FINAL.pdf
 
COMPILED VERSION Sbh who good pharmacy practice(gpp)
COMPILED VERSION Sbh who good pharmacy practice(gpp)COMPILED VERSION Sbh who good pharmacy practice(gpp)
COMPILED VERSION Sbh who good pharmacy practice(gpp)
 
Essential medicines and counterfeit medicines
Essential medicines and counterfeit medicinesEssential medicines and counterfeit medicines
Essential medicines and counterfeit medicines
 
Hashim 2-1.pptx
Hashim 2-1.pptxHashim 2-1.pptx
Hashim 2-1.pptx
 
WHO PROMOTING rATIONAL USE OF MEDICINES.pdf
WHO PROMOTING rATIONAL USE OF MEDICINES.pdfWHO PROMOTING rATIONAL USE OF MEDICINES.pdf
WHO PROMOTING rATIONAL USE OF MEDICINES.pdf
 
Drug Utilization Studies
Drug Utilization StudiesDrug Utilization Studies
Drug Utilization Studies
 
Pharmacovigilance
PharmacovigilancePharmacovigilance
Pharmacovigilance
 
GROWTH OF PHARMACOVIGILANCE IN INDIA Dr Deven V Parmar MD Vice President – Gl...
GROWTH OF PHARMACOVIGILANCE IN INDIA Dr Deven V Parmar MD Vice President – Gl...GROWTH OF PHARMACOVIGILANCE IN INDIA Dr Deven V Parmar MD Vice President – Gl...
GROWTH OF PHARMACOVIGILANCE IN INDIA Dr Deven V Parmar MD Vice President – Gl...
 
Tbsrud3nov09
Tbsrud3nov09Tbsrud3nov09
Tbsrud3nov09
 
Essential medicine
Essential medicineEssential medicine
Essential medicine
 
PV UTILISATION, APPLICATION WHO PROGRAMME.pptx
PV UTILISATION, APPLICATION WHO PROGRAMME.pptxPV UTILISATION, APPLICATION WHO PROGRAMME.pptx
PV UTILISATION, APPLICATION WHO PROGRAMME.pptx
 
Unit 3 drug utilization research (6hrs) march 12 2021
Unit 3 drug utilization research (6hrs) march 12 2021Unit 3 drug utilization research (6hrs) march 12 2021
Unit 3 drug utilization research (6hrs) march 12 2021
 
Drugs
DrugsDrugs
Drugs
 
REGULATION OF COMPLEMENTARY MEDICINES.pptx
REGULATION OF COMPLEMENTARY MEDICINES.pptxREGULATION OF COMPLEMENTARY MEDICINES.pptx
REGULATION OF COMPLEMENTARY MEDICINES.pptx
 
Introduction_Pharmacotherapeutics.pptx
Introduction_Pharmacotherapeutics.pptxIntroduction_Pharmacotherapeutics.pptx
Introduction_Pharmacotherapeutics.pptx
 

Recently uploaded

Low Rate Call Girls Pune Esha 9907093804 Short 1500 Night 6000 Best call girl...
Low Rate Call Girls Pune Esha 9907093804 Short 1500 Night 6000 Best call girl...Low Rate Call Girls Pune Esha 9907093804 Short 1500 Night 6000 Best call girl...
Low Rate Call Girls Pune Esha 9907093804 Short 1500 Night 6000 Best call girl...Miss joya
 
Call Girls Hosur Just Call 7001305949 Top Class Call Girl Service Available
Call Girls Hosur Just Call 7001305949 Top Class Call Girl Service AvailableCall Girls Hosur Just Call 7001305949 Top Class Call Girl Service Available
Call Girls Hosur Just Call 7001305949 Top Class Call Girl Service Availablenarwatsonia7
 
VIP Call Girls Pune Vrinda 9907093804 Short 1500 Night 6000 Best call girls S...
VIP Call Girls Pune Vrinda 9907093804 Short 1500 Night 6000 Best call girls S...VIP Call Girls Pune Vrinda 9907093804 Short 1500 Night 6000 Best call girls S...
VIP Call Girls Pune Vrinda 9907093804 Short 1500 Night 6000 Best call girls S...Miss joya
 
Call Girls ITPL Just Call 7001305949 Top Class Call Girl Service Available
Call Girls ITPL Just Call 7001305949 Top Class Call Girl Service AvailableCall Girls ITPL Just Call 7001305949 Top Class Call Girl Service Available
Call Girls ITPL Just Call 7001305949 Top Class Call Girl Service Availablenarwatsonia7
 
Call Girls Service Chennai Jiya 7001305949 Independent Escort Service Chennai
Call Girls Service Chennai Jiya 7001305949 Independent Escort Service ChennaiCall Girls Service Chennai Jiya 7001305949 Independent Escort Service Chennai
Call Girls Service Chennai Jiya 7001305949 Independent Escort Service ChennaiNehru place Escorts
 
Kolkata Call Girls Services 9907093804 @24x7 High Class Babes Here Call Now
Kolkata Call Girls Services 9907093804 @24x7 High Class Babes Here Call NowKolkata Call Girls Services 9907093804 @24x7 High Class Babes Here Call Now
Kolkata Call Girls Services 9907093804 @24x7 High Class Babes Here Call NowNehru place Escorts
 
Call Girl Koramangala | 7001305949 At Low Cost Cash Payment Booking
Call Girl Koramangala | 7001305949 At Low Cost Cash Payment BookingCall Girl Koramangala | 7001305949 At Low Cost Cash Payment Booking
Call Girl Koramangala | 7001305949 At Low Cost Cash Payment Bookingnarwatsonia7
 
Call Girls Hsr Layout Just Call 7001305949 Top Class Call Girl Service Available
Call Girls Hsr Layout Just Call 7001305949 Top Class Call Girl Service AvailableCall Girls Hsr Layout Just Call 7001305949 Top Class Call Girl Service Available
Call Girls Hsr Layout Just Call 7001305949 Top Class Call Girl Service Availablenarwatsonia7
 
call girls in green park DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in green park  DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️call girls in green park  DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in green park DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️saminamagar
 
Hemostasis Physiology and Clinical correlations by Dr Faiza.pdf
Hemostasis Physiology and Clinical correlations by Dr Faiza.pdfHemostasis Physiology and Clinical correlations by Dr Faiza.pdf
Hemostasis Physiology and Clinical correlations by Dr Faiza.pdfMedicoseAcademics
 
Russian Call Girl Brookfield - 7001305949 Escorts Service 50% Off with Cash O...
Russian Call Girl Brookfield - 7001305949 Escorts Service 50% Off with Cash O...Russian Call Girl Brookfield - 7001305949 Escorts Service 50% Off with Cash O...
Russian Call Girl Brookfield - 7001305949 Escorts Service 50% Off with Cash O...narwatsonia7
 
Artifacts in Nuclear Medicine with Identifying and resolving artifacts.
Artifacts in Nuclear Medicine with Identifying and resolving artifacts.Artifacts in Nuclear Medicine with Identifying and resolving artifacts.
Artifacts in Nuclear Medicine with Identifying and resolving artifacts.MiadAlsulami
 
High Profile Call Girls Jaipur Vani 8445551418 Independent Escort Service Jaipur
High Profile Call Girls Jaipur Vani 8445551418 Independent Escort Service JaipurHigh Profile Call Girls Jaipur Vani 8445551418 Independent Escort Service Jaipur
High Profile Call Girls Jaipur Vani 8445551418 Independent Escort Service Jaipurparulsinha
 
Call Girls Service Nandiambakkam | 7001305949 At Low Cost Cash Payment Booking
Call Girls Service Nandiambakkam | 7001305949 At Low Cost Cash Payment BookingCall Girls Service Nandiambakkam | 7001305949 At Low Cost Cash Payment Booking
Call Girls Service Nandiambakkam | 7001305949 At Low Cost Cash Payment BookingNehru place Escorts
 
Ahmedabad Call Girls CG Road 🔝9907093804 Short 1500 💋 Night 6000
Ahmedabad Call Girls CG Road 🔝9907093804  Short 1500  💋 Night 6000Ahmedabad Call Girls CG Road 🔝9907093804  Short 1500  💋 Night 6000
Ahmedabad Call Girls CG Road 🔝9907093804 Short 1500 💋 Night 6000aliya bhat
 
Glomerular Filtration and determinants of glomerular filtration .pptx
Glomerular Filtration and  determinants of glomerular filtration .pptxGlomerular Filtration and  determinants of glomerular filtration .pptx
Glomerular Filtration and determinants of glomerular filtration .pptxDr.Nusrat Tariq
 
Aspirin presentation slides by Dr. Rewas Ali
Aspirin presentation slides by Dr. Rewas AliAspirin presentation slides by Dr. Rewas Ali
Aspirin presentation slides by Dr. Rewas AliRewAs ALI
 
Russian Call Girls in Pune Riya 9907093804 Short 1500 Night 6000 Best call gi...
Russian Call Girls in Pune Riya 9907093804 Short 1500 Night 6000 Best call gi...Russian Call Girls in Pune Riya 9907093804 Short 1500 Night 6000 Best call gi...
Russian Call Girls in Pune Riya 9907093804 Short 1500 Night 6000 Best call gi...Miss joya
 

Recently uploaded (20)

Low Rate Call Girls Pune Esha 9907093804 Short 1500 Night 6000 Best call girl...
Low Rate Call Girls Pune Esha 9907093804 Short 1500 Night 6000 Best call girl...Low Rate Call Girls Pune Esha 9907093804 Short 1500 Night 6000 Best call girl...
Low Rate Call Girls Pune Esha 9907093804 Short 1500 Night 6000 Best call girl...
 
Call Girls Hosur Just Call 7001305949 Top Class Call Girl Service Available
Call Girls Hosur Just Call 7001305949 Top Class Call Girl Service AvailableCall Girls Hosur Just Call 7001305949 Top Class Call Girl Service Available
Call Girls Hosur Just Call 7001305949 Top Class Call Girl Service Available
 
VIP Call Girls Pune Vrinda 9907093804 Short 1500 Night 6000 Best call girls S...
VIP Call Girls Pune Vrinda 9907093804 Short 1500 Night 6000 Best call girls S...VIP Call Girls Pune Vrinda 9907093804 Short 1500 Night 6000 Best call girls S...
VIP Call Girls Pune Vrinda 9907093804 Short 1500 Night 6000 Best call girls S...
 
Call Girls ITPL Just Call 7001305949 Top Class Call Girl Service Available
Call Girls ITPL Just Call 7001305949 Top Class Call Girl Service AvailableCall Girls ITPL Just Call 7001305949 Top Class Call Girl Service Available
Call Girls ITPL Just Call 7001305949 Top Class Call Girl Service Available
 
Call Girls Service Chennai Jiya 7001305949 Independent Escort Service Chennai
Call Girls Service Chennai Jiya 7001305949 Independent Escort Service ChennaiCall Girls Service Chennai Jiya 7001305949 Independent Escort Service Chennai
Call Girls Service Chennai Jiya 7001305949 Independent Escort Service Chennai
 
Kolkata Call Girls Services 9907093804 @24x7 High Class Babes Here Call Now
Kolkata Call Girls Services 9907093804 @24x7 High Class Babes Here Call NowKolkata Call Girls Services 9907093804 @24x7 High Class Babes Here Call Now
Kolkata Call Girls Services 9907093804 @24x7 High Class Babes Here Call Now
 
Escort Service Call Girls In Sarita Vihar,, 99530°56974 Delhi NCR
Escort Service Call Girls In Sarita Vihar,, 99530°56974 Delhi NCREscort Service Call Girls In Sarita Vihar,, 99530°56974 Delhi NCR
Escort Service Call Girls In Sarita Vihar,, 99530°56974 Delhi NCR
 
Call Girl Koramangala | 7001305949 At Low Cost Cash Payment Booking
Call Girl Koramangala | 7001305949 At Low Cost Cash Payment BookingCall Girl Koramangala | 7001305949 At Low Cost Cash Payment Booking
Call Girl Koramangala | 7001305949 At Low Cost Cash Payment Booking
 
Call Girls Hsr Layout Just Call 7001305949 Top Class Call Girl Service Available
Call Girls Hsr Layout Just Call 7001305949 Top Class Call Girl Service AvailableCall Girls Hsr Layout Just Call 7001305949 Top Class Call Girl Service Available
Call Girls Hsr Layout Just Call 7001305949 Top Class Call Girl Service Available
 
call girls in green park DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in green park  DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️call girls in green park  DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in green park DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
 
Hemostasis Physiology and Clinical correlations by Dr Faiza.pdf
Hemostasis Physiology and Clinical correlations by Dr Faiza.pdfHemostasis Physiology and Clinical correlations by Dr Faiza.pdf
Hemostasis Physiology and Clinical correlations by Dr Faiza.pdf
 
Russian Call Girl Brookfield - 7001305949 Escorts Service 50% Off with Cash O...
Russian Call Girl Brookfield - 7001305949 Escorts Service 50% Off with Cash O...Russian Call Girl Brookfield - 7001305949 Escorts Service 50% Off with Cash O...
Russian Call Girl Brookfield - 7001305949 Escorts Service 50% Off with Cash O...
 
Artifacts in Nuclear Medicine with Identifying and resolving artifacts.
Artifacts in Nuclear Medicine with Identifying and resolving artifacts.Artifacts in Nuclear Medicine with Identifying and resolving artifacts.
Artifacts in Nuclear Medicine with Identifying and resolving artifacts.
 
High Profile Call Girls Jaipur Vani 8445551418 Independent Escort Service Jaipur
High Profile Call Girls Jaipur Vani 8445551418 Independent Escort Service JaipurHigh Profile Call Girls Jaipur Vani 8445551418 Independent Escort Service Jaipur
High Profile Call Girls Jaipur Vani 8445551418 Independent Escort Service Jaipur
 
sauth delhi call girls in Bhajanpura 🔝 9953056974 🔝 escort Service
sauth delhi call girls in Bhajanpura 🔝 9953056974 🔝 escort Servicesauth delhi call girls in Bhajanpura 🔝 9953056974 🔝 escort Service
sauth delhi call girls in Bhajanpura 🔝 9953056974 🔝 escort Service
 
Call Girls Service Nandiambakkam | 7001305949 At Low Cost Cash Payment Booking
Call Girls Service Nandiambakkam | 7001305949 At Low Cost Cash Payment BookingCall Girls Service Nandiambakkam | 7001305949 At Low Cost Cash Payment Booking
Call Girls Service Nandiambakkam | 7001305949 At Low Cost Cash Payment Booking
 
Ahmedabad Call Girls CG Road 🔝9907093804 Short 1500 💋 Night 6000
Ahmedabad Call Girls CG Road 🔝9907093804  Short 1500  💋 Night 6000Ahmedabad Call Girls CG Road 🔝9907093804  Short 1500  💋 Night 6000
Ahmedabad Call Girls CG Road 🔝9907093804 Short 1500 💋 Night 6000
 
Glomerular Filtration and determinants of glomerular filtration .pptx
Glomerular Filtration and  determinants of glomerular filtration .pptxGlomerular Filtration and  determinants of glomerular filtration .pptx
Glomerular Filtration and determinants of glomerular filtration .pptx
 
Aspirin presentation slides by Dr. Rewas Ali
Aspirin presentation slides by Dr. Rewas AliAspirin presentation slides by Dr. Rewas Ali
Aspirin presentation slides by Dr. Rewas Ali
 
Russian Call Girls in Pune Riya 9907093804 Short 1500 Night 6000 Best call gi...
Russian Call Girls in Pune Riya 9907093804 Short 1500 Night 6000 Best call gi...Russian Call Girls in Pune Riya 9907093804 Short 1500 Night 6000 Best call gi...
Russian Call Girls in Pune Riya 9907093804 Short 1500 Night 6000 Best call gi...
 

WHO Essential Medicine List, India's National List of Essential Med & Rational Use of Drugs

  • 1. Essential Medicines List: Concept and Procedures 1 | WHO ESSENTIAL MEDICINES LIST WHO ESSENTIAL MEDICINES LIST Dr. AMREEN SABA ATTARIYA POST GRADUATE STUDENT DEPT OF PHARMACOLOGY M.R. MEDICAL COLLEGE, GULBARGA, INDIA
  • 2. Essential Medicines List: Concept and Procedures 2 | Outline of the presentation  Background  Evolution of WHO- Essential Medicine List(EML) (1977-2013)  Approach for Revising/Updating the WHO Model EML  Use of WHO Model EML and Implementation by National Health Systems  Factors Affecting the Implementation of EML on Country Level  Model EML  India-National List of Essential Medicines(NLEM)  Rational use of drugs  Summary & References
  • 3. Essential Medicines List: Concept and Procedures 3 |  GUIDING PRINCIPLE: A limited range of carefully selected essential drugs leads to Better health care, Better drug management & at Lower costs  DEFINITION: That satisfy the priority health care needs of the population at all time.  SELECTION: with due regard to public health relevance, evidence of efficacy and safety, and comparative cost-effectiveness* ESSENTIAL MEDICINES *WHO, [Online]. http://www.who.int/topics/essential_medicines/en
  • 4. Essential Medicines List: Concept and Procedures 4 | EM are intended to be available –at all times – adequate amounts –appropriate dosage forms –assured quality & adequate information –at a price the individual & community can afford.
  • 5. Essential Medicines List: Concept and Procedures 5 | First country to compose its EML Tanzania in 1970 HISTORY OF WHO MODEL LIST OF ESSENTIAL DRUGS … 39 yrs of EML • 1977 First Model list published, 204 active substances List is revised every 2 years by WHO Expert Committee April 2003 revised Model list --- 315 active substances 2007-EMLca separate list for children up to 12 years Latest editions 19th adults & 5thchildren in April 2015(ammended Nov2015)* *“WHO Model List of Essential Medicines: 18th list”, 2015.
  • 6. Essential Medicines List: Concept and Procedures 6 | CRITERIA FOR DRUG SELECTION FOR EML Evidence of efficacy & safety Relative cost effectiveness Pharmacokinetics Availability Desired dosage form, bioavailability & stability ensured Single compounds , in some cases FDCs
  • 7. Essential Medicines List: Concept and Procedures 7 | 19th WHO Model List of Essential Medicines - 2015 Report of the WHO Expert Committee, 2015
  • 8. Essential Medicines List: Concept and Procedures 8 | Evolution of the WHO EML with Number of Additions & Deletions
  • 9. Essential Medicines List: Concept and Procedures 9 | Significant changes from 1977 - 2013 Significant net changes in 1979 list 1988-Addition of FDC for TB 2007- newly developed vaccines for Hep-A, rotavirus etc. 2013- Anti-retroviral drugs
  • 10. Essential Medicines List: Concept and Procedures 10 | CORE & COMPLEMENTARY LISTS Core List Medicines  minimum drug needs for a basic health care system  most cost-effective drugs for priority conditions Based on: Efficacy & safety Cost-effectiveness
  • 11. Essential Medicines List: Concept and Procedures 11 | Complementary List Medicines : Treat a priority condition Require special: Diagnostic or monitoring facilities Medical care Training Consistently higher cost or minimal cost-effectiveness
  • 12. Essential Medicines List: Concept and Procedures 12 | SYMBOLS square box symbol () - similar clinical performance within a pharmacological class. a- age or weight restriction on use of medicine [c] -complementary list [c] -specific indication for restricting its use in children
  • 13. Essential Medicines List: Concept and Procedures 13 | EML 2013 in numbers Adult List 374 – total number of drugs/medicines – Core list: 282 (FDC: 23) – Complementary list: 68 (FDC: 1) Pediatric List 278 in total – Core list: 206 (FDC: 11) – Complementary list: 60 (FDC: 1)
  • 14. Essential Medicines List: Concept and Procedures 14 | Trend for the Number of Medicines for Non- Communicable Diseases
  • 15. Essential Medicines List: Concept and Procedures 15 | Trend for the Number of Medicines for Non- Communicable Diseases… Despite projections by the WHO that NCDs73% of death burden & 60% of disease burden by 2020* The ratio of medicines for NCD medicines to total number of medicines in the WHO EML is constant at ~15% from 1977-2013 * WHO NCD surveillance strategy
  • 16. Essential Medicines List: Concept and Procedures 16 | Trend for Inclusion of Vaccine WHO-Expanded Program on Immunization -1974 to cover 6 diseases* *MA Miller, JT Sentz., Chapter 12,“Vaccine-Preventable Diseases”, in: DT Jamison, RG Feachem, MW Makgoba, et al., editors. “Disease and Mortality in Sub-Saharan Africa”, 2nd edition. Washington (DC): World Bank; 2006. DIPHTHERIA PERTUSIS TETANUS TB POLIOMYELITIS MEASLES
  • 17. Essential Medicines List: Concept and Procedures 17 | Evolution of Vaccines in the WHO EML with Number of Additions and Deletions Cholera HIB Hepatitis A JE Pneumococcal Rotavirus varicella
  • 18. Essential Medicines List: Concept and Procedures 18 | Expansion of therapy classes(1977-2013)* *“Selection of Essential Medicines – a Background Paper for theWorld Medicines Situation 2010 Report”, 2009
  • 19. Essential Medicines List: Concept and Procedures 19 | Seven steps to get a new medicine on the WHO Model List of Essential Drugs 1. Identification of public-health need for a medicine 2. Development of the medicine; phase I - II - III trials 3. Regulatory approval in a number of countries 4. Post-marketing surveillance 5. Price indication for public sector use 6. Review by WHO disease programme; define safety , comparative cost-effectiveness and public health relevance 7. Submission to WHO Expert Committee on Essential Drugs
  • 20. Essential Medicines List: Concept and Procedures 20 | PROCESS EVIDENCE BASED & TRANSPARENT Applications - addition/deletion /modification Peer-reviewed by Expert Committee(EC) Comments invited from any one interested EC makes final decisions
  • 21. Essential Medicines List: Concept and Procedures 21 | The application form/template
  • 22. Essential Medicines List: Concept and Procedures 22 | Notable changes in EML since its inception “Essential Drugs”  “Essential Medicines,” Experience based Evidence based Introduction of more rational selection process Total treatment approach cost effectiveness approach
  • 23. Essential Medicines List: Concept and Procedures 23 | Important Events of EML* *WHO, “Alliance for Health Policy and Systems Research;Medicines in Health Systems: Advancing access, affordability and appropriate use”, Flagship Report, 2014
  • 24. Essential Medicines List: Concept and Procedures 24 | Key Responsibilities of Different Stakeholders as Defined at the Nairobi Conference-1985* GOVERNMENT Establish & implement national drug policy Create awareness among health personnel & public Increase registration of acceptable & safe drugs by setting up or strengthening drug regulatory authority *WHO, “The Rational Use of Drugs - Report of the Conference of Experts, Nairobi 25-29 November 1985”,
  • 25. Essential Medicines List: Concept and Procedures 25 | PHARMACEUTICAL INDUSTRIES Complete & unbiased product info to all -govt, prescribers & consumers Comply with established drug promotional criteria & adopt ethical code for drug promotion Respond to need of developing countries for low-cost drugs Develop new drugs in neglected fields with high unmet needs
  • 26. Essential Medicines List: Concept and Procedures 26 | PRESCRIBERS Prescribe rationally in conformity with health, social & economic criteria Transparent & accurate info on healthcare & drug therapy to patients & public
  • 27. Essential Medicines List: Concept and Procedures 27 | UNIVERSITIES/ TEACHING INSTITUTIONS Improve training of health workers in healthcare in general & in rational use of drugs Introduce the concept of essential drugs Continuing education to health care providers General education on proper health care & drug therapy
  • 28. Essential Medicines List: Concept and Procedures 28 | PUBLIC , PATIENT & CONSUMER Improve relevance & quality of information for public Share responsibility with govt. & non-govt. organizations for education of consumers Support essential drug program
  • 29. Essential Medicines List: Concept and Procedures 29 | MASS MEDIA Provide relevant & balanced information on health matters, including drug therapy Share in public education on proper use of drug therapy
  • 30. Essential Medicines List: Concept and Procedures 30 | Use of WHO Model List Major International Agencies -UNICEF, UNHCR- United Nations High Commissioner for Refugees Sub-sets: UN list of recommended essential drugs for emergency relief, interagency New Emergency Health Kit. Normative Tools: WHO Model Formulary, International Pharmacopoea, Basic Quality Tests & development of reference standards
  • 31. Essential Medicines List: Concept and Procedures 31 | Current Process and Steps in Updating WHO Model EML
  • 32. Essential Medicines List: Concept and Procedures 32 | Use of WHO Model EML & Implementation by National Health Systems Guides the procurement & supply in public sector Reimbursement schemes for medicine cost, medicine donation & local production. 95% countries have NATIONAL LIST OF ESSENTIAL MEDICINES(NLEM)of which 86% update once in 5yrs* Few adopt EML at sub-national or state/provincial level *WHO, “Backgrounder and Facts for Launch of the United Nations Report Delivering on the Global Partnerships for Achieving The Millennium Development Goals”.
  • 33. Essential Medicines List: Concept and Procedures 33 | Number of countries with NLEM National Essential Drugs List < 5 years (127) > 5 years (29) No NEDL (19) Unknown (16)
  • 34. Essential Medicines List: Concept and Procedures 34 | Difference between WHO-EML & NLEM WHO EML- insulin & metformin “Medicines used for Diabetics” NLEM India & China- “Hormones, Other Endocrine Medicines WHO EML-only names of medicines & recommended formulations & strengths NLEM-recommended standard treatment guidelines for the specific indication in an attempt to align the EML with the country-specific standard treatment guidelines.
  • 35. Essential Medicines List: Concept and Procedures 35 | Factors Affecting the Implementation of EML on country level Pricing Policy Availability Of Essential Medicines Reimbursement Scenario Government Initiatives Supporting Implementation Patent & Licensing Scenario Healthcare Infrastructure
  • 36. Essential Medicines List: Concept and Procedures 36 |
  • 37. Essential Medicines List: Concept and Procedures 37 | Access to Essential Medicines in Public and Private Health Facilities No. of people without access is high A survey in 27 developing countries in 2007average availability of EM in public sector- 34.9%, private sector- 63.2%* *WHO, “Continuity and Change – Implementing the Third Who Medicines Strategy 2008 m-2013”, 2009.
  • 38. Essential Medicines List: Concept and Procedures 38 | Factors for Low availability of EML in public sectors underfunding or under-budgeting inaccurate demand forecasting inefficient public sector procurement & distribution of med COMPELS PATIENTS INTO PRIVATE SECTOR AVAILABILITY IS HIGH BUT COSTLY
  • 39. Essential Medicines List: Concept and Procedures 39 | Median Availability of Selected Generics in Public and Private Health Facilities Across Low and Middle Income Level Countries
  • 40. Essential Medicines List: Concept and Procedures 40 | Comparison of Medicines for Selected NCDs and CDs
  • 41. Essential Medicines List: Concept and Procedures 41 | Content of EML 1 Anaesthetics 1.1 General anaesthetics and oxygen 1.2 Local anaesthetics 1.3 Preoperative medication and sedation for short-term procedures 2 Medicines for pain and palliative care 2.1 Non-opioids and non-steroidal anti-inflammatory drugs (NSAIDs) 2.2 Opioid analgesics 2.3 Medicines for other common symptoms in palliative care 3 Antiallergics and medicines used in anaphylaxis 4 Antidotes and other substances used in poisonings 4.1 Non-specific 4.2 Specific 5 Anticonvulsants/antiepileptics 6 Anti-infective medicines 6.1 Antihelminthics 6.2 Antibacterials 6.3 Antifungal medicines 6.4 Antiviral medicines 6.5 Antiprotozoal medicines etc,……………………………………….
  • 42. Essential Medicines List: Concept and Procedures 42 | Content of EML 7 Antimigraine medicines 7.1 For treatment of acute attack 7.2 For prophylaxis Hormones, other endocrine medicines and cont Immunologicals Ophthalmological preparations Vitamins and minerals Medicines for diseases of joints Ear, nose and throat medicines in children Cardiovascular medicines Antiparkinsonism medicines Diagnostic agents Diuretics Gastrointestinal medicines
  • 43. Essential Medicines List: Concept and Procedures 43 |
  • 44. Essential Medicines List: Concept and Procedures 44 |
  • 45. Essential Medicines List: Concept and Procedures 45 | INDIA - NLEM
  • 46. Essential Medicines List: Concept and Procedures 46 | Executive Core Committee INDIA By Ministry of Health & Family Welfare (MOHFW), GOI Under chairmanship of Dr VM Katoch - Secretary, Department of Health Research (DHR) and Director General ICMR & Dr YK Gupta- Vice Chairman, Professor and Head, Dept of Pharmacology AIIMS.
  • 47. Essential Medicines List: Concept and Procedures 47 | Criteria For Inclusion Of Medicine In NLEM* Be approved/licensed by DCGI. Be useful in Disease which is a public health problem in India.  Proven efficacy & safety profile based on valid scientific evidence. Be comparatively Cost effective. Aligned with the current treatment guidelines for the disease. Stable under the storage conditions in India. *Report of core committee for revision of India NLEM Nov-2015
  • 48. Essential Medicines List: Concept and Procedures 48 | Criteria for Deletion of Medicine from NLEM Medicines banned Availability of med with better safety, efficacy & cost- effectiveness. Disease burden no longer health concern. Antimicrobials resistance pattern rendered a medicine ineffective.
  • 49. Essential Medicines List: Concept and Procedures 49 | Salient Features Of NLEM First NLEM-1996 NLEM 2011  348 med NLEM 2015  376 medicines(106 added & 70 deleted) 3 category included  P→ Primary  S → Secondary  T → Tertiary P,S,T ---206 drugs S,T --- 115drugs T --- 79 drugs.
  • 50. Essential Medicines List: Concept and Procedures 50 | NLEM 2015- BEST FIT LIST Adhering To The Basic Principles Of Efficacy Safety Cost-Effectiveness Consideration of diseases as public health problems in India.
  • 51. Essential Medicines List: Concept and Procedures 51 | NLEM-2015
  • 52. Essential Medicines List: Concept and Procedures 52 |
  • 53. Essential Medicines List: Concept and Procedures 53 |
  • 54. Essential Medicines List: Concept and Procedures 54 |
  • 55. Essential Medicines List: Concept and Procedures 55 |
  • 56. Essential Medicines List: Concept and Procedures 56 | Practical Applications of EML Policy making Management Selection Procurement Distribution Quality assurance Financing
  • 57. Essential Medicines List: Concept and Procedures 57 | Promoting rational use Training of health Professionals For providing medicines information & education Cost effective therapy
  • 58. Essential Medicines List: Concept and Procedures 58 | Purpose of the NLEM Guides safe and effective treatment of priority disease conditions of a population  Promote the rational use of medicines Optimize the available health resources of a country
  • 59. Essential Medicines List: Concept and Procedures 59 | NLEM-a guiding document for State governments to prepare their list of essential medicines Procurement and supply of medicines in the public sector Reimbursement of cost of medicines by organizations to its employees Reimbursement by insurance companies Identifying the ‘MUST KNOW’ domain for the teaching & training of health care professionals
  • 60. Essential Medicines List: Concept and Procedures 60 | Rational use of dRugs
  • 61. Essential Medicines List: Concept and Procedures 61 | Rational use of Drug Patients receive medications appropriate to their clinical needs, in doses that meet their own individual requirements for an adequate period of time, and at the lowest cost to them and their community. WHO conference of experts Nairobi 1985  correct drug  appropriate indication  appropriate drug considering efficacy, safety, suitability for the patient & cost  appropriate dosage, administration, duration  no contraindications  correct dispensing, including appropriate information for patients  patient adherence to treatment
  • 62. Essential Medicines List: Concept and Procedures 62 | Rational use of Drug* RULE OF RIGHT RIGHT DRUG to RIGHT PATIENT in RIGHT DOSAGE @ RIGHT COST SANE CRITERIA SAFETY, AFFORDABILITY,NEED & EFFICACY *HL Sharma & KL Sharma:Concept of EM & Rational drug use, p.no-106, 2nd ed.
  • 63. Essential Medicines List: Concept and Procedures 63 | Factors Influencing Use of Medicines Treatment Choices Prior Knowledge Habits Scientific Information Relationships With Peers Influence of Drug Industry Workload & Staffing Infra- structure Authority & Supervision Societal Information Intrinsic Workplace Workgroup Social & Cultural Factors Economic & Legal Factors
  • 64. Essential Medicines List: Concept and Procedures 64 | SUMMARY Defn: EM -that satisfy the priority health care needs of the population at all time Selection criteria: with due regard to public health relevance, evidence of efficacy and safety & comparative cost-effectiveness First model list-1977, revised every 2yrs, latest is 19th– adults & 5th - children(2015) Core list- basic min drugs for priority diseases Complementary- which requires specialised health care facility
  • 65. Essential Medicines List: Concept and Procedures 65 | SUMMARY…  Steps for getting new drug in model list Identification of problem devp of med regulatory approval PMS pricing review by WHO disease program submission to WHO EC.  Changes since inception EDL EML, experience evidence, total rxcost effectiveness  Key responsibilties of govt, pharmac companies, prescribers, public, patient, consumers & mass media
  • 66. Essential Medicines List: Concept and Procedures 66 | SUMMARY… Factors affecting implementation Pricing, availabilty, patent & licensing issues, health care infrastructure Access to EML  public sector<<<<private sector Uses of EML- Policy making, Management, Selection, Procurement, Distribution, Financing, Promoting rational use, Training of health Professionals, For providing medicines info & education, Cost effective therapy
  • 67. Essential Medicines List: Concept and Procedures 67 | SUMMARY… INDIA –NLEM By MOHW- Govt Of India 3 categories- pri, sec & ter NLEM-2015—376 molecules(BEST FIT LIST) Adheres to safety, efficacy & cost-effective approach
  • 68. Essential Medicines List: Concept and Procedures 68 | References  Understanding the Role and Use of EML: Murray Aitken Executive Director IMS Institute for Healthcare Informatics, USA April 2015.  WHO, [Online]. Available: http://www.who.int/medicines/publications/essentialmedicines/en/  WHO, “WHO Model List of Essential Medicines: 19th list”, 2015.  Brian M. Kaiser : WHO’s EML: From Idea to Implementation  WHO, “Essential Medicines for NCDs”, 2011.  Report of core committee for revision of India NLEM Nov-2015  HL Sharma & KL Sharma:Concept of EM & Rational drug use, p.no-106, 2nd ed.

Editor's Notes

  1. Essential medicines are intended to be available within the context of functioning health systems at all times in adequate amounts, in the appropriate dosage forms, with assured quality &amp; adequate information at a price the individual &amp; community can afford.
  2. Addition of new drugs is based on documented evidence of efficacy, relative efficacy, safety and comparative cost- effectiveness while reasons for deletions include lack of proof of effectiveness, unacceptable side effects or availability of safer or more effective alternatives.
  3. Significant net change was observed in the 1979 list, probably since the list was in the process of being developed and established •• Addition of fixed dose combinations for tuberculosis to the list contributed to the significant change observed in 1998 •• Addition of agents in 2003 is mainly attributed to the inclusion of anti-retroviral drugs to the EML •• Significant change observed in 2007 can be attributed to the inclusion of various newly developed vaccines to the list, including hepatitis A vaccine, rotavirus vaccine, etc.
  4. Core list-minimum drug needs for a basic health care system, listing the most cost-effective drugs for priority conditions (selected on the basis of burden of disease and potential for safe and cost-effective treatment).
  5. COMPLEMENTARY LIST: essential drugs for priority diseases which are cost-effective but not necessarily affordable or for which specialised health care facilities may be needed; and essential drugs for less frequent diseases.* In case of doubt, medicines may also be listed as complementary on the basis of consistent higher costs or less attractive cost-effectiveness in a variety of settings
  6. The importance of ensuring access to appropriate medicines for treating NCDs is reflected in the consistent increase in the number of medicines for NCDs in the WHO EML
  7. The selection of the original EPI vaccines was made on programmatic criteria rather than consideration of disease burden. A few vaccines, such as YF and JE, have regional importance based on prevalence. The WHO EML included JE after 27 years of inclusion of YF, even though there is no evidence that the disease burden of YF is greater than JE
  8. Additions and deletions across therapy areas in the EML reflect the evolving focus areas and public health challenges. Anti-infectives appear to be the area with the highest increase, presumably driven by the addition of therapies for evolving health concerns such as tuberculosis, malaria, and HIV. Anti-neoplastic agents, hormones, and vaccines are the other therapy areas with the highest number of drugs added to the original list
  9. Applications invited &amp; received - addition/deletion /modification Peer-reviewed by Expert Committee(EC) members (2 or 3 independent reviewers) Comments invited from any one interested (WHO Depts., Professional Societies, International agencies, Academia) EC makes final decisions
  10. 1. Use of the term “Essential Medicines” as an alternative to “Essential Drugs,” reflecting the common use of the term “medicines” to describe pharmaceutical preparations used in clinical practice 2. Evolution from being experience-based to evidence-based 3. Introduction of a more rationalized selection process where research evidence was relied upon for evaluating comparative benefit and safety of specific medicines 4. Use of a comparative cost-effectiveness approach which is presented as a range of cost per routine outcome (e.g., cost per case, cost per cure, cost per month of treatment) compared to older methods where cost of the total treatment was taken into account
  11. GOVERNMENT Establish and implement national drug policy with national health policy Create awareness of EML among health personnel &amp; public Increase registration of acceptable &amp; safe drugs by setting up or strengthening drug regulatory authority
  12. Provide complete and unbiased product information to all concerned -governments, prescribers and consumers Comply with established drug promotional criteria &amp; adopt ethical code for drug promotion Respond to the need of developing countries for low-cost drugs Develop new drugs in neglected fields with high unmet needs
  13. Prescribe rationally in conformity with health, as well as social and economic criteria Provide transparent and accurate information on healthcare and drug therapy to patients and public
  14. Improve training of health workers in healthcare in general and in rational use of drugs Introduce the concept of essential drugs Provide continuing education for health care providers Provide general education on proper health care and drug therapy also to those not training as health workers
  15. Improve the relevance and quality of information for the public Share responsibility with govt. and non-govt. organizations for the education of consumers on drug matters Support essential drug program
  16. Provide relevant and balanced information on health matters, including drug therapy Share in public education on the proper use of drug therapy
  17. Major international agencies (UNICEF united nations childrens emergency fund, UNHCR-United Nations High Commissioner for Refugees) base their catalogue on WHO Model List Sub-sets: UN list of recommended essential drugs for emergency relief (85 drugs); interagency New Emergency Health Kit (55 drugs for 10,000 consultations) Normative tools: WHO Model Formulary, International Pharmacopoea, Basic Quality Tests, and development of reference standards follow the WHO Model List
  18. Guides the procurement &amp; supply in public sector Reimbursement schemes for medicine cost, medicine donation &amp; local production. 95% countries have NATIONAL LIST OF ESSENTIAL MEDICINES(NLEM)of which 86% update once in 5yrs* Few adopt EML at sub-national or state/provincial level
  19. WHO Model list contains only the names of medicines and recommended formulations and strengths, while the lists for some of the countries also include the recommended standard treatment guidelines for the specific indication in an attempt to align the EML with the country-specific standard treatment guidelines
  20. --Access to EML is improved but still the no. of people without access is high --Survey done for measuring medicine availability, price, affordability &amp; price components --A survey in 27 developing countries in 2007average availability of EM in public sector was only 34.9%, while in the private sector was 63.2%
  21. The square box symbol is primarily intended to indicate similar clinical performance within a pharmacological class The a(in square box) symbol indicates that there is an age or weight restriction on use of the medicine c- complementary c- specific indication for restricting its use to children
  22. The Core-Committee was constituted by the Ministry of Health &amp; Family Welfare (MOHFW), Government of India, under the chairmanship of Dr VM Katoch, the then Secretary, Department of Health Research (DHR) and Director General, Indian Council of Medical Research (ICMR), and Dr YK Gupta, Professor and Head, Department of Pharmacology, All India Institute of Medical Sciences (AIIMS) as the Vice Chairman.
  23. The medicine should be approved/licensed in India. – The medicine should be useful in disease which is a public health problem in India. – The medicine should have proven efficacy and safety profile based on valid scientific evidence. – The medicine should be cost effective. – The medicine should be aligned with the current treatment guidelines for the disease. – The medicine should be stable under the storage conditions in India. – When more than one medicine are available from the same therapeutic class, preferably one prototype/ medically best suited medicine of that class to be included after due deliberation and careful evaluation of their relative safety, efficacy, cost-effectiveness.
  24. The medicine has been banned in India. – There are reports of concerns on the safety profile of a medicine. – A medicine with better efficacy or favorable safety profiles and better cost-effectiveness is now available. – The disease burden for which a medicine is indicated is no longer a national health concern in India. – In case of antimicrobials, if the resistance pattern has rendered a medicine ineffective in Indian context.
  25. Medicines in NLEM are listed with reference to the levels of healthcare, namely, Primary (P), Secondary (S) and Tertiary (T). There are 209 medicine formulations listed for all levels of health care (P, S, T), 115 medicine formulations for secondary and tertiary levels (S, T) and 79 medicine formulations for the tertiary level (T).
  26. a guiding document for State governments to prepare their list of essential medicines b) Procurement and supply of medicines in the public sector c) Reimbursement of cost of medicines by organizations to its employees d) Reimbursement by insurance companies e) Identifying the ‘MUST KNOW’ domain for the teaching and training of health care professionals
  27. Rational use of drugs is based on rule of right It shd fulfil SANE criteria